Serious infections and malignancies following the administration of adalimumab (Humira) to patients with rheumatoid arthritis

Fragkou, D; Galanis, P

Galanis, P (reprint author), 67 Mikras Asias St, GR-11527 Athens, Greece.

ARCHIVES OF HELLENIC MEDICINE, 2017; 34 (2): 165

Abstract

Adalimumab is a biological agent, and specifically it is a fully human anti-tumor necrosis factor-alpha (TNF-alpha) monoclonal antibody, which is the ......

Full Text Link